Nature Reviews Neurology最新文献

筛选
英文 中文
Nanoprobe for blood–brain barrier changes 检测血脑屏障变化的纳米探针
IF 38.1 1区 医学
Nature Reviews Neurology Pub Date : 2024-05-14 DOI: 10.1038/s41582-024-00971-x
Lisa Kiani
{"title":"Nanoprobe for blood–brain barrier changes","authors":"Lisa Kiani","doi":"10.1038/s41582-024-00971-x","DOIUrl":"10.1038/s41582-024-00971-x","url":null,"abstract":"","PeriodicalId":19085,"journal":{"name":"Nature Reviews Neurology","volume":"20 6","pages":"316-316"},"PeriodicalIF":38.1,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140919700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR T cells offer hope in glioblastoma CAR T 细胞为胶质母细胞瘤带来希望
IF 38.1 1区 医学
Nature Reviews Neurology Pub Date : 2024-05-14 DOI: 10.1038/s41582-024-00972-w
Ian Fyfe
{"title":"CAR T cells offer hope in glioblastoma","authors":"Ian Fyfe","doi":"10.1038/s41582-024-00972-w","DOIUrl":"10.1038/s41582-024-00972-w","url":null,"abstract":"Novel CAR T cells delivered directly to the CNS could have therapeutic effects in recurrent glioblastoma, according to two early-stage trials.","PeriodicalId":19085,"journal":{"name":"Nature Reviews Neurology","volume":"20 6","pages":"315-315"},"PeriodicalIF":38.1,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140919735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clinical importance of suspected non-Alzheimer disease pathophysiology 疑似非阿尔茨海默病病理生理学的临床重要性
IF 38.1 1区 医学
Nature Reviews Neurology Pub Date : 2024-05-09 DOI: 10.1038/s41582-024-00962-y
Stephanie J. B. Vos, Aurore Delvenne, Clifford R. Jack Jr, Dietmar R. Thal, Pieter Jelle Visser
{"title":"The clinical importance of suspected non-Alzheimer disease pathophysiology","authors":"Stephanie J. B. Vos, Aurore Delvenne, Clifford R. Jack Jr, Dietmar R. Thal, Pieter Jelle Visser","doi":"10.1038/s41582-024-00962-y","DOIUrl":"10.1038/s41582-024-00962-y","url":null,"abstract":"The development of biomarkers for Alzheimer disease (AD) has led to the origin of suspected non-AD pathophysiology (SNAP) — a heterogeneous biomarker-based concept that describes individuals with normal amyloid and abnormal tau and/or neurodegeneration biomarker status. In this Review, we describe the origins of the SNAP construct, along with its prevalence, diagnostic and prognostic implications, and underlying neuropathology. As we discuss, SNAP can be operationalized using different biomarker modalities, which could affect prevalence estimates and reported characteristics of SNAP in ways that are not yet fully understood. Moreover, the underlying aetiologies that lead to a SNAP biomarker profile, and whether SNAP is the same in people with and without cognitive impairment, remains unclear. Improved insight into the clinical characteristics and pathophysiology of SNAP is of major importance for research and clinical practice, as well as for trial design to optimize care and treatment of individuals with SNAP. Suspected non-AD pathophysiology (SNAP) is a biomarker-based concept that describes individuals with normal amyloid and abnormal tau and/or neurodegeneration biomarker status. This Review discusses the origins of the SNAP construct, along with its prevalence, diagnostic and prognostic implications, and underlying neuropathology.","PeriodicalId":19085,"journal":{"name":"Nature Reviews Neurology","volume":"20 6","pages":"337-346"},"PeriodicalIF":38.1,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140895564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in epilepsy — applications and pathways to the clinic 人工智能在癫痫中的应用及临床路径
IF 38.1 1区 医学
Nature Reviews Neurology Pub Date : 2024-05-08 DOI: 10.1038/s41582-024-00965-9
Alfredo Lucas, Andrew Revell, Kathryn A. Davis
{"title":"Artificial intelligence in epilepsy — applications and pathways to the clinic","authors":"Alfredo Lucas, Andrew Revell, Kathryn A. Davis","doi":"10.1038/s41582-024-00965-9","DOIUrl":"10.1038/s41582-024-00965-9","url":null,"abstract":"Artificial intelligence (AI) is rapidly transforming health care, and its applications in epilepsy have increased exponentially over the past decade. Integration of AI into epilepsy management promises to revolutionize the diagnosis and treatment of this complex disorder. However, translation of AI into neurology clinical practice has not yet been successful, emphasizing the need to consider progress to date and assess challenges and limitations of AI. In this Review, we provide an overview of AI applications that have been developed in epilepsy using a variety of data modalities: neuroimaging, electroencephalography, electronic health records, medical devices and multimodal data integration. For each, we consider potential applications, including seizure detection and prediction, seizure lateralization, localization of the seizure-onset zone and assessment for surgical or neurostimulation interventions, and review the performance of AI tools developed to date. We also discuss methodological considerations and challenges that must be addressed to successfully integrate AI into clinical practice. Our goal is to provide an overview of the current state of the field and provide guidance for leveraging AI in future to improve management of epilepsy. Integration of artificial intelligence into epilepsy management could revolutionize diagnosis and treatment. In this Review, the authors provide an overview of artificial intelligence applications that have been developed in epilepsy and discuss challenges that must be addressed to successfully integrate artificial intelligence into clinical practice.","PeriodicalId":19085,"journal":{"name":"Nature Reviews Neurology","volume":"20 6","pages":"319-336"},"PeriodicalIF":38.1,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140881290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Correction: The complex aetiology of cerebral palsy 作者更正:脑瘫的复杂病因。
IF 38.1 1区 医学
Nature Reviews Neurology Pub Date : 2024-04-25 DOI: 10.1038/s41582-024-00964-w
Steven J. Korzeniewski, Jaime Slaughter, Madeleine Lenski, Peterson Haak, Nigel Paneth
{"title":"Author Correction: The complex aetiology of cerebral palsy","authors":"Steven J. Korzeniewski, Jaime Slaughter, Madeleine Lenski, Peterson Haak, Nigel Paneth","doi":"10.1038/s41582-024-00964-w","DOIUrl":"10.1038/s41582-024-00964-w","url":null,"abstract":"","PeriodicalId":19085,"journal":{"name":"Nature Reviews Neurology","volume":"20 6","pages":"377-377"},"PeriodicalIF":38.1,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41582-024-00964-w.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuronal activity drives glymphatic waste clearance 神经元活动驱动甘液废物清除
IF 38.1 1区 医学
Nature Reviews Neurology Pub Date : 2024-04-15 DOI: 10.1038/s41582-024-00963-x
Lisa Kiani
{"title":"Neuronal activity drives glymphatic waste clearance","authors":"Lisa Kiani","doi":"10.1038/s41582-024-00963-x","DOIUrl":"10.1038/s41582-024-00963-x","url":null,"abstract":"Two new studies show that clearance of waste, including pathogenic amyloid, through the glymphatic system is driven by synchronized neuronal activity.","PeriodicalId":19085,"journal":{"name":"Nature Reviews Neurology","volume":"20 5","pages":"255-255"},"PeriodicalIF":38.1,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140556817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurofilaments as biomarkers in neurological disorders — towards clinical application 作为神经系统疾病生物标记物的神经丝--走向临床应用
IF 38.1 1区 医学
Nature Reviews Neurology Pub Date : 2024-04-12 DOI: 10.1038/s41582-024-00955-x
Michael Khalil, Charlotte E. Teunissen, Sylvain Lehmann, Markus Otto, Fredrik Piehl, Tjalf Ziemssen, Stefan Bittner, Maria Pia Sormani, Thomas Gattringer, Samir Abu-Rumeileh, Simon Thebault, Ahmed Abdelhak, Ari Green, Pascal Benkert, Ludwig Kappos, Manuel Comabella, Hayrettin Tumani, Mark S. Freedman, Axel Petzold, Kaj Blennow, Henrik Zetterberg, David Leppert, Jens Kuhle
{"title":"Neurofilaments as biomarkers in neurological disorders — towards clinical application","authors":"Michael Khalil, Charlotte E. Teunissen, Sylvain Lehmann, Markus Otto, Fredrik Piehl, Tjalf Ziemssen, Stefan Bittner, Maria Pia Sormani, Thomas Gattringer, Samir Abu-Rumeileh, Simon Thebault, Ahmed Abdelhak, Ari Green, Pascal Benkert, Ludwig Kappos, Manuel Comabella, Hayrettin Tumani, Mark S. Freedman, Axel Petzold, Kaj Blennow, Henrik Zetterberg, David Leppert, Jens Kuhle","doi":"10.1038/s41582-024-00955-x","DOIUrl":"10.1038/s41582-024-00955-x","url":null,"abstract":"Neurofilament proteins have been validated as specific body fluid biomarkers of neuro-axonal injury. The advent of highly sensitive analytical platforms that enable reliable quantification of neurofilaments in blood samples and simplify longitudinal follow-up has paved the way for the development of neurofilaments as a biomarker in clinical practice. Potential applications include assessment of disease activity, monitoring of treatment responses, and determining prognosis in many acute and chronic neurological disorders as well as their use as an outcome measure in trials of novel therapies. Progress has now moved the measurement of neurofilaments to the doorstep of routine clinical practice for the evaluation of individuals. In this Review, we first outline current knowledge on the structure and function of neurofilaments. We then discuss analytical and statistical approaches and challenges in determining neurofilament levels in different clinical contexts and assess the implications of neurofilament light chain (NfL) levels in normal ageing and the confounding factors that need to be considered when interpreting NfL measures. In addition, we summarize the current value and potential clinical applications of neurofilaments as a biomarker of neuro-axonal damage in a range of neurological disorders, including multiple sclerosis, Alzheimer disease, frontotemporal dementia, amyotrophic lateral sclerosis, stroke and cerebrovascular disease, traumatic brain injury, and Parkinson disease. We also consider the steps needed to complete the translation of neurofilaments from the laboratory to the management of neurological diseases in clinical practice. Neurofilaments have been validated as specific body fluid biomarkers of neuro-axonal injury. In this Review, Khalil and colleagues provide an update on the structure and function of neurofilaments, analytical approaches and challenges in different clinical contexts, and progress towards clinical application of neurofilaments as a biomarker in various neurological disorders.","PeriodicalId":19085,"journal":{"name":"Nature Reviews Neurology","volume":"20 5","pages":"269-287"},"PeriodicalIF":38.1,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140550531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing disparities in neurology by identifying gaps in hospital care 通过确定医院护理中的差距来解决神经内科的差距问题
IF 38.1 1区 医学
Nature Reviews Neurology Pub Date : 2024-04-12 DOI: 10.1038/s41582-024-00960-0
Lisa Kiani
{"title":"Addressing disparities in neurology by identifying gaps in hospital care","authors":"Lisa Kiani","doi":"10.1038/s41582-024-00960-0","DOIUrl":"10.1038/s41582-024-00960-0","url":null,"abstract":"Nature Reviews Neurology is interviewing individuals who are driving efforts to address disparities in neurology through a broad spectrum of diversity, equity and inclusion initiatives. We spoke with neurosurgeon Sonia Mejía Pérez from Mexico about her work to address gaps in hospital care for individuals from minority groups, such as LGBT+ people.","PeriodicalId":19085,"journal":{"name":"Nature Reviews Neurology","volume":"20 5","pages":"253-254"},"PeriodicalIF":38.1,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140547573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EBV-specific T cells in multiple sclerosis 多发性硬化症中的 EBV 特异性 T 细胞
IF 38.1 1区 医学
Nature Reviews Neurology Pub Date : 2024-04-10 DOI: 10.1038/s41582-024-00959-7
Heather Wood
{"title":"EBV-specific T cells in multiple sclerosis","authors":"Heather Wood","doi":"10.1038/s41582-024-00959-7","DOIUrl":"10.1038/s41582-024-00959-7","url":null,"abstract":"New data recently reported at the ACTRIMS Forum add to growing evidence of an aetiological role for Epstein–Barr virus infection in multiple sclerosis.","PeriodicalId":19085,"journal":{"name":"Nature Reviews Neurology","volume":"20 5","pages":"255-255"},"PeriodicalIF":38.1,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140541409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BTK inhibitor falters in multiple sclerosis trials BTK抑制剂在多发性硬化症试验中表现不佳
IF 38.1 1区 医学
Nature Reviews Neurology Pub Date : 2024-04-10 DOI: 10.1038/s41582-024-00958-8
Heather Wood
{"title":"BTK inhibitor falters in multiple sclerosis trials","authors":"Heather Wood","doi":"10.1038/s41582-024-00958-8","DOIUrl":"10.1038/s41582-024-00958-8","url":null,"abstract":"Findings of phase III trials of the Bruton’s tyrosine kinase inhibitor evobrutinib in patients with relapsing multiple sclerosis were recently presented at the ACTRIMS Forum.","PeriodicalId":19085,"journal":{"name":"Nature Reviews Neurology","volume":"20 5","pages":"255-255"},"PeriodicalIF":38.1,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140541232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信